Sanna Bastiano Insider Trades

Insider Trading History

Track insider trading activity for Sanna Bastiano. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adicet Bio
Adicet Bio ACET
Director
Holding Value $0 0 shares
Last Trade
Aug 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$160k 74,900 shares
$2.14
$8.15
Adicet Bio
Adicet Bio ACET
Director
Holding Value $235k 28,828 shares
Last Trade
Aug 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 74,900 shares
$2.14
$8.15
Adicet Bio
Adicet Bio ACET
Director
Holding Value $215k 26,400 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$168k 32,300 shares
$5.20
$8.15
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $14.2M 32,038 shares
Last Trade
May 08, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$998k 2,850 shares
$350.00
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $15.4M 34,888 shares
Last Trade
May 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$148k 422 shares
$350.03
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $15.9M 36,038 shares
Last Trade
May 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$975k 2,781 shares
$350.74
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $16.9M 38,302 shares
Last Trade
May 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$569k 1,622 shares
$350.66
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $20.5M 46,406 shares
Last Trade
Apr 12, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.47M 7,567 shares
$326.70
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $21M 47,591 shares
Last Trade
Apr 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$165k 522 shares
$315.81
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $21.1M 47,802 shares
Last Trade
Mar 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$460k 1,466 shares
$313.74
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $21.9M 49,532 shares
Last Trade
Mar 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$825k 2,746 shares
$300.59
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $23M 52,014 shares
Last Trade
Feb 24, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.15M 3,970 shares
$289.12
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $24.7M 55,984 shares
Last Trade
Feb 17, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.1M 3,750 shares
$292.85
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $26.5M 60,013 shares
Last Trade
Feb 14, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$655k 2,181 shares
$300.39
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $27.4M 62,028 shares
Last Trade
Feb 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.29M 4,340 shares
$298.26
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $27.4M 61,915 shares
Last Trade
Feb 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$33.9k 113 shares
$300.39
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $29.3M 66,368 shares
Last Trade
Feb 10, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$265k 902 shares
$294.33
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $29.7M 67,270 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.29M 29,272 shares
$317.27
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $16.8M 37,998 shares
Last Trade
Jan 31, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$34.5k 106 shares
$325.00
$441.74
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Cell & Genetic Therapies
Holding Value $16.9M 38,368 shares
Last Trade
Nov 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$100k 320 shares
$312.64
$441.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up